ReP USP - Resultado da busca

Filtros : "Host-directed therapy" Limpar

Filtros

USP affiliated authors
- costa, diego luís (~2)
- correa, andré aparecido dos santos (~1)
- matteucci, kely catarine (~1)
Date published
- 2022 (~1)
- 2021 (~1)
Subjects
- farmacoterapia (2)
- mycobacterium tuberculosis (2)
- tuberculose (2)
- agentes antimicrobianos (1)
- antígenos de bactérias (1)

Artigo de periodico
Recent advances in host-directed therapies for tuberculosis and malaria (2022)
Matteucci, Kely Catarine ; Correa, André Aparecido dos Santos; Costa, Diego Luís
Source: Frontiers in Cellular and Infection Microbiology. Unidade: FMRP
Subjects: TUBERCULOSE, MALÁRIA, FARMACOTERAPIA, MYCOBACTERIUM TUBERCULOSIS, PLASMODIUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATTEUCCI, Kely Catarine e CORREA, André Aparecido dos Santos e COSTA, Diego Luís. Recent advances in host-directed therapies for tuberculosis and malaria. Frontiers in Cellular and Infection Microbiology, v. 12, 2022Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2022.905278. Acesso em: 09 fev. 2026.
APA
Matteucci, K. C., Correa, A. A. dos S., & Costa, D. L. (2022). Recent advances in host-directed therapies for tuberculosis and malaria. Frontiers in Cellular and Infection Microbiology, 12. doi:10.3389/fcimb.2022.905278
NLM
Matteucci KC, Correa AA dos S, Costa DL. Recent advances in host-directed therapies for tuberculosis and malaria [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12[citado 2026 fev. 09 ] Available from: https://doi.org/10.3389/fcimb.2022.905278
Vancouver
Matteucci KC, Correa AA dos S, Costa DL. Recent advances in host-directed therapies for tuberculosis and malaria [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12[citado 2026 fev. 09 ] Available from: https://doi.org/10.3389/fcimb.2022.905278
Artigo de periodico
Enhancement of CD4+ T Cell function as a strategy for improving antibiotic therapy efficacy in tuberculosis: does it work? (2021)
Costa, Diego Luís ; Amaral, Eduardo P.; Namasivayam, Sivaranjani; Mittereder, Lara R.; Andrade, Bruno B.; Sher, Alan
Source: Frontiers in Cellular and Infection Microbiology. Unidade: FMRP
Subjects: AGENTES ANTIMICROBIANOS, ANTÍGENOS DE BACTÉRIAS, MYCOBACTERIUM TUBERCULOSIS, TUBERCULOSE, VACINAS, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Diego Luís et al. Enhancement of CD4+ T Cell function as a strategy for improving antibiotic therapy efficacy in tuberculosis: does it work?. Frontiers in Cellular and Infection Microbiology, v. 11, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2021.672527. Acesso em: 09 fev. 2026.
APA
Costa, D. L., Amaral, E. P., Namasivayam, S., Mittereder, L. R., Andrade, B. B., & Sher, A. (2021). Enhancement of CD4+ T Cell function as a strategy for improving antibiotic therapy efficacy in tuberculosis: does it work? Frontiers in Cellular and Infection Microbiology, 11, 1-12. doi:10.3389/fcimb.2021.672527
NLM
Costa DL, Amaral EP, Namasivayam S, Mittereder LR, Andrade BB, Sher A. Enhancement of CD4+ T Cell function as a strategy for improving antibiotic therapy efficacy in tuberculosis: does it work? [Internet]. Frontiers in Cellular and Infection Microbiology. 2021 ; 11 1-12.[citado 2026 fev. 09 ] Available from: https://doi.org/10.3389/fcimb.2021.672527
Vancouver
Costa DL, Amaral EP, Namasivayam S, Mittereder LR, Andrade BB, Sher A. Enhancement of CD4+ T Cell function as a strategy for improving antibiotic therapy efficacy in tuberculosis: does it work? [Internet]. Frontiers in Cellular and Infection Microbiology. 2021 ; 11 1-12.[citado 2026 fev. 09 ] Available from: https://doi.org/10.3389/fcimb.2021.672527

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2026